NVIDIA (NASDAQ: NVDA) shares surged 8.8% Tuesday, recovering from a sharp sell-off linked to DeepSeek’s claims, which wiped $589 billion off the AI chip giant's market value. The rebound came as Wall Street analysts rallied to defend NVIDIA, urging investors to seize this buying opportunity.
DeepSeek, a Chinese AI startup, caused ripples Monday by claiming it built its advanced AI model for under $6 million, challenging industry heavyweights like OpenAI, Google, Microsoft, and Tesla. The announcement drew comparisons to “AI’s Sputnik moment” by Marc Andreessen, but skepticism emerged about DeepSeek’s reliance on NVIDIA’s Hopper GPUs, estimated at nearly $2 billion, and Meta’s Llama models, which also demand significant investment.
Wedbush analyst Dan Ives dismissed the sell-off as an overreaction, labeling it a "golden buying opportunity." Tigress Financial’s Ivan Feinseth upgraded NVIDIA to “Strong Buy” with a 12-month price target of $220, citing the company’s dominance in AI development and robust cash flow growth. He called the dip a strategic entry point for investors.
Morgan Stanley analyst Joseph Moore acknowledged DeepSeek’s innovative approach but viewed its market impact as limited, noting NVIDIA’s strong pipeline with upcoming Blackwell GPUs. Moore, however, trimmed his price target to $152–$166, citing short-term demand softness due to delayed Hopper orders.
Despite Monday’s 17% drop, NVIDIA remains a cornerstone of the AI sector, with shares up 94% year-over-year. Analysts agree that NVIDIA’s leadership in AI infrastructure and continued innovation will drive sustained growth, positioning it to capitalize on the ongoing AI adoption wave across industries.
Investors are now closely watching NVIDIA’s next moves amid the evolving competitive landscape.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



